CoChat

Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients

Open access
Charpentier, G., Fleury, F., Kabir, M., Vaur, L., Halimi, S. · 2001 · Diabetic Medicine
Cited by 151

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Aim To compare the effect of glimepiride in combination with metformin with monotherapy of each drug on glycaemic control in Type 2 diabetic patients. Design and methods Randomized, double‐blind, double‐dummy, parallel‐group multicentre study conducted in France. Type 2 diabetic patients aged 35–70 years inadequately controlled by metformin monotherapy 2550 mg daily for at least 4 weeks were randomized to either metformin, glimepiride or metformin and glimepiride. Results Three hundred and seventy‐two patients aged 56 ± 8 years were treated for 5 months. Combination treatment was significantly more efficient in controlling HbA 1c (% change + 0.07 ± 1.20 for metformin, + 0.27 ± 1.10 for glimepiride, −0.74 ± 0.96 for combination treatment, P < 0.001), fasting blood glucose (FBG) (mmol/l change + 0.8 ± 0.4 for metformin, + 0.7 ± 3.1 for glimepiride and −1.8 ± 2.2 for combination treatment, P < 0.001) and post‐prandial blood glucose (PPBG) (mmol/l change + 1.1 ± 5.9 for metformin, + 0.1 ± 5.1 for glimepiride and −2.6 ± 3.9 for combination treatment, P < 0.001) than either glimepiride or metformin alone. There was no significant difference between metformin or glimepiride monotherapy with respect to the change in HbA 1c or FBG; however, glimepiride was significantly more effective than metformin in reducing PPBG. The incidence of symptomatic hypoglycaemia was higher in the combination group than in either monotherapy group (P = 0.039). Conclusions Addition of glimepiride to metformin in Type 2 diabetic patients inadequately controlled by metformin alone resulted in superior glycaemic control compared with glimepiride or metformin monotherapy. Diabet. Med. 18, 828–834 (2001)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2001.00582.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 151

Metadata

Authors
Charpentier, G., Fleury, F., Kabir, M., Vaur, L., & Halimi, S.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2001-10
Volume
18
Issue
10
Pages
828-834
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2138470202
Cited by
151
References
9
FWCI
4.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients. https://app.cochat.ai/papers/10.1046/j.1464-5491.2001.00582.x
The paper
Charpentier, G., Fleury, F., Kabir, M., Vaur, L., & Halimi, S. (2001). Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2001.00582.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.